For the drug development, pre-IND meeting is a critical tool to discuss the needs and challenges specific to the general product development, nonclinical testing, manufacturing information, protocol design or other regulatory questions defined in the Code of Federal Regulations (21 CFR 312.82). https://www.creative-biolabs.com/immuno-oncology/pre-ind-meeting.htm

1. Creative
-biolabs
SOLUTIONS OVERVIEW
Creative Biolabs’s expertise in bioassay and the experience gained from our
hundreds of projects have enabled us to work closely with our clients to provide
scientific and experimental expertise in the design and implementation of tailored
bioassays.
ADCC, CDC, and ADCP > Immunoassay > Immune Checkpoint Assays >
FcR Binding Assay > Tissue Cross-Reactivity Studies > Immune Cells Function Assays >
Immuno-Oncology Assay > Contamination Testing > Viral Clearance Studies >
Biosafety Testing > Protein Characterization > HCP Analysis>
Bioassays for Antibody and Protein
Creative Biolabs Confidential
4